Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Retatrutide is an investigational triple receptor agonist currently under clinical development
Peptide therapy should only be administered under the supervision of a qualified healthcare provider
Whether youre dealing with anxiety, depression, ADHD, or another challenge, we offer personalized treatment and compassionate support to help you find balance and healing
Contraindications Based on Mechanism Active mental health crisis or suicidal ideation (unproven intervention should never delay evidence-based emergency care) Pregnancy or breastfeeding (no safety data, potential for developmental effects given neuroprotective/neuroplastic actions) Bleeding disorders (BPC-157 affects thrombocyte function) Immune system disorders (concerns about potential immune reactions) Frequently Asked Questions What is BPC-157 and where does it come from
Geroscience 42 , 667686 (2020)
Retatrutide has a more advanced mechanism than tirzepatide, and Lilly will price it accordingly
US$ 20.69
US$ 22.20
US$ 29.85
US$ 28.40
